We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-0.51%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$61.6B
AUM Growth
+$1.91B
(+3.2%)
Cap. Flow
+$2.64B
Cap. Flow
% of AUM
4.28%
Top 10 Holdings %
Top 10 Hldgs %
19.17%
Holding
769
New
56
Increased
370
Reduced
204
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$259M |
| 2 |
Liberty Media Series C
FWONK
|
+$253M |
| 3 |
Oracle
ORCL
|
+$232M |
| 4 |
Avery Dennison
AVY
|
+$230M |
| 5 |
Emerson Electric
EMR
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$236M |
| 2 |
Liberty Media Series A
FWONA
|
+$224M |
| 3 |
State Street
STT
|
+$220M |
| 4 |
Parker-Hannifin
PH
|
+$185M |
| 5 |
Lear
LEA
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.21% |
| 2 | Technology | 15.31% |
| 3 | Healthcare | 14.81% |
| 4 | Energy | 10.39% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MJN
426
DELISTED
Mead Johnson Nutrition Company
MJN
| $8.32M | 0.01% |
86,500
+29,700
| +52% | +$2.81M |
|
427
MYR Group
MYRG
$5.9B
| $8.28M | 0.01% |
343,990
+17,630
| +5% | +$432K |
|
|
PRGX
428
DELISTED
PRGX Global, Inc.
PRGX
| $8.28M | 0.01% |
1,412,231
-202,309
| -13% | -$1.27M |
|
429
NCR Voyix
VYX
$1.06B
| $8.27M | 0.01% |
403,560
+167,608
| +71% | +$3.4M |
|
430
Credicorp
BAP
$30.9B
| $8.22M | 0.01% |
53,614
-10,000
| -16% | -$1.53M |
|
431
ICF International
ICFI
$1.44B
| $8.18M | 0.01% |
265,802
+30,363
| +13% | +$1.04M |
|
|
RLOG
432
DELISTED
Rand Logistics, Inc.
RLOG
| $8.03M | 0.01% |
1,408,212
+24,338
| +2% | +$148K |
|
|
GLBR
433
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $8M | 0.01% |
50,488
+46,872
| +1,296% | +$6.68M |
|
|
REN
434
DELISTED
Resolute Energy Corporaton
REN
| $7.96M | 0.01% |
253,748
-41,686
| -14% | -$1.58M |
|
435
Fresenius Medical Care
FMS
$13.2B
| $7.83M | 0.01% |
225,515
| – | – |
|
436
Generac Holdings
GNRC
$11.9B
| $7.8M | 0.01% |
+192,470
| New | +$8.62M |
|
437
Mueller Industries
MLI
$14.1B
| $7.75M | 0.01% |
1,085,848
-431,764
| -28% | -$3.13M |
|
|
QTS
438
DELISTED
QTS REALTY TRUST, INC.
QTS
| $7.72M | 0.01% |
254,435
+5,962
| +2% | +$176K |
|
439
Dillards
DDS
$8.87B
| $7.62M | 0.01% |
69,894
+7,932
| +13% | +$922K |
|
|
CQB
440
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
| $7.58M | 0.01% |
533,680
-264,481
| -33% | -$3.24M |
|
441
WSFS Financial
WSFS
$4.1B
| $7.46M | 0.01% |
312,330
-1,710
| -0.5% | -$41.3K |
|
|
MCF
442
DELISTED
Contango Oil & Gas Co.
MCF
| $7.43M | 0.01% |
223,604
+855
| +0.4% | +$33.4K |
|
443
TETRA Technologies
TTI
$1.23B
| $7.43M | 0.01% |
686,720
-115,820
| -14% | -$1.32M |
|
444
Sensient Technologies
SXT
$5.4B
| $7.4M | 0.01% |
141,292
+5,843
| +4% | +$318K |
|
|
BBG
445
DELISTED
Bill Barrett Corp
BBG
| $7.29M | 0.01% |
330,620
+126,550
| +62% | +$2.95M |
|
446
Urban Outfitters
URBN
$5.99B
| $7.27M | 0.01% |
198,000
+19,400
| +11% | +$713K |
|
447
US Physical Therapy
USPH
$1.14B
| $7.25M | 0.01% |
204,769
-69,335
| -25% | -$2.45M |
|
|
UIL
448
DELISTED
UIL HOLDINGS
UIL
| $7.24M | 0.01% |
204,570
-1,320
| -0.6% | -$48.3K |
|
|
CTT
449
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $7.22M | 0.01% |
+658,410
| New | +$7.88M |
|
450
Stewart Information Services
STC
$2.05B
| $7.21M | 0.01% |
245,524
+5,280
| +2% | +$164K |
|
Similar funds
Boston Partners's Q3 2014 Portfolio in Review
As of Q3 2014, Boston Partners held 769 positions worth $61.6B, up 3.2% from $59.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Boston Partners deployed $2.64B of net new capital in Q3 2014, opening 56 new positions and adding to 370 existing holdings. Its largest new stake was Liberty Media Series C: 9,903,335 shares worth $249M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was ROCK-TENN COMPANY CL-A, an estimated $236M trimmed.
- Boston Partners's largest Q3 2014 buy was Liberty Media Series C: 9,903,335 shares worth $249M.
- Boston Partners added most to Teva Pharmaceuticals in Q3 2014, an estimated $259M increase.
- Boston Partners's biggest Q3 2014 reduction was ROCK-TENN COMPANY CL-A, cutting an estimated $236M.
- Boston Partners fully exited Cigna in Q3 2014, selling an estimated $133M.
- Boston Partners's ten largest holdings make up 19% of its $61.6B portfolio in Q3 2014.
- Boston Partners opened 56 new positions and closed 51 in Q3 2014.
- Boston Partners's portfolio value rose 3.2% quarter-over-quarter to $61.6B.
Based on Boston Partners's 13F filing for Q3 2014, filed 12 Nov 2014.